Edwards Lifesciences Corporation Common Stock vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.46 (market cap $127.85B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 2.6× Edwards Lifesciences Corporation Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.72% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | MFG | |
|---|---|---|
Market Cap | $48.56B | $127.85B |
Volume | 6,520,488 | 3,950,750 |
Sector | Health | Financials |
52-Week High | $95.18 | $11.45 |
52-Week Low | $72.65 | $6.09 |
Enterprise Value | $45.01B | $35.14T |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 1.72% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →